Top Markets
Coin of the day
Roche Holding AG Roche Holding AG

Roche Holding AG

ROG
Rangering i aksjer #37
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in... Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.
Aksjekurs
$419.17
Markedsverdi
$333.66B
Endring (1 dag)
0.50%
Endring (1 år)
14.13%
Land
CH
Handel Roche Holding AG (ROG)

Kategori

Inntekter for Roche Holding AG (ROG)
Inntekter i Dec 2025 TTM: $77.52B
Ifølge de nyeste økonomiske rapportene til Roche Holding AG er selskapets nåværende inntekter (TTM) $77.52B. I 2024 hadde selskapet inntekter på $69.07B en nedgang sammenlignet med inntektene i 2023, som var $71.87B. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Roche Holding AG fra 2000 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $77.52B 0.00%
2025 $77.52B 12.23%
2024 $69.07B -3.89%
2023 $71.87B 0.96%
2022 $71.19B 3.34%
2021 $68.88B 6.09%
2020 $64.93B -1.48%
2019 $65.90B 8.96%
2018 $60.48B 5.74%
2017 $57.20B 10.60%
2016 $51.72B 2.56%
2015 $50.42B 0.45%
2014 $50.20B -7.86%
2013 $54.48B 9.59%
2012 $49.71B 9.80%
2011 $45.28B -10.87%
2010 $50.80B 7.01%
2009 $47.47B 11.15%
2008 $42.71B 4.63%
2007 $40.82B 18.37%
2006 $34.48B 27.80%
2005 $26.98B -1.91%
2004 $27.51B 8.99%
2003 $25.24B 17.44%
2002 $21.49B 22.59%
2001 $17.53B -0.62%
2000 $17.64B 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land